1.Innate immune recognition of the pathogenic parasites by toll-like receptors.
Xiaobing HE ; Huaijie JIA ; Zhizhong JING
Chinese Journal of Biotechnology 2012;28(12):1401-1413
Toll-like receptors (TLRs) have emerged as major receptor components of pattern-recognition receptors (PRRs), which are responsible for the recognition of pathogen-associated molecular patterns (PAMPs)-derived pathogenic parasites. This recognition triggers the secretion of a large amount of type I interferons (IFNs), inflammatory cytokines, and chemokines and maturation of immune cells, for effective host defense by eradicating infectious parasites. Both the myeloid differentiation factor 88 (MyD88) and the TIR domain containing the adaptor molecule (TRIF) are involved in these signaling pathways. Here, we review the latest findings on the recognition of the pathogenic parasites and activation of corresponding signaling pathways through TLRs, with special emphasis on the recognition of pathogenic protozoan and helminthes. By highlighting recent progress in these areas, we hope to provide references in future studies not only for the complexity of host-parasite interactions but also for the prevention of the pathogenic parasite infections.
Animals
;
Host-Parasite Interactions
;
immunology
;
Humans
;
Immunity, Innate
;
immunology
;
Malaria, Falciparum
;
parasitology
;
Plasmodium falciparum
;
immunology
;
Signal Transduction
;
Toll-Like Receptors
;
immunology
;
Trypanosoma
;
immunology
;
Trypanosomiasis
;
parasitology
2.Immunity of peritoneal monocytes against Plasmodium yoelii infected erythrocytes.
Ying-hong MAO ; Jie YUAN ; Bao-feng LIU
Acta Academiae Medicinae Sinicae 2004;26(4):415-417
OBJECTIVETo test the immunity of peritoneal monocytes against Plasmodium yoelii infected red blood cells (target cells).
METHODSSaponinized Plasmodium yoelii infected red blood cells (SPRBC, Ghost erythrocyte) were used to immunize mice i.p twice. Three weeks later, the infected red blood cells were injected i.p.; 90 min later, the total peritoneal cells were isolated and washed for scanning electromicroscopy to observe the effects of the peritoneal monocyte to the target cell.
RESULTSThe peritoneal cells of the immunized mice were activated after 90 min of the challenge of target cells. The size of the cell was not even and the pili on the cell surface turned to be long and densed. Cell interconnections were found among the cells. In some peritoneal monocytes, their cell plasma were scattered (omlette-like) or with the shape as "cellular bomb". The scattered or the sheeted pili and spredding cell plasma could adhere to the target cells which were perforated densely and damaged.
CONCLUSIONThe protective adaptive immunity exists in the peritoneal monocytes of immunized mice.
Animals ; Antibodies, Protozoan ; immunology ; Erythrocyte Membrane ; parasitology ; Female ; Malaria Vaccines ; immunology ; Mice ; Mice, Inbred BALB C ; Monocytes ; immunology ; ultrastructure ; Peritoneum ; cytology ; Plasmodium yoelii ; immunology ; ultrastructure
3.Induction of protective immunity in rhesus monkey by inoculation with recombinant fusion protein of cholera toxin B subunit-multivalent epitopes of Plasmodium falciparum.
Ping LI ; Hui ZHONG ; Cheng-Hua SHI ; Jie-Zhi LI ; Yan-Hong ZHANG ; Chu-Fang LI ; Yun-Lin SHI ; Qing-Jun MA ; Cheng CAO
Chinese Journal of Biotechnology 2004;20(4):516-519
Rhesus monkeys (5 in each group) were inoculated with recombinant fusion protein of cholera toxin B subunit and multi-valent epitopes of Plasmodium falciparum intranasal or intramuscular (i.m.). Immune-responses and protective effect were evaluated. The antibody titer (Geometry mean) against CTB reached 1:512 (intranasal) and 1:10000 (i.m.) 14 day after 3rd immunization, and antibodies against P. falciparum were also elucidated, the titers in i.m. group were also significantly higher than that in intranasal group. The monkeys were challenged with 1.25 x 10(8) sporozoites of P. cynomolgi, Patent infection was observed in all 5 monkeys in control group inoculated with PBS in 10 - 14 days after challenge. Patent infection was also observed in 5 animals inoculated via intranasal and 2 animals in intramuscular group 19th days after challenge, But the infection last only 4 days in 3 animals in intranasal group and 2 animals in intramuscular group. The results demonstrated that the vaccine candidate could induce protective immune-responses in rhesus monkey against the challenge of P. cynomolgi.
Animals
;
Antibodies, Bacterial
;
blood
;
Antibodies, Protozoan
;
blood
;
Cholera Toxin
;
genetics
;
immunology
;
Erythrocytes
;
parasitology
;
Macaca mulatta
;
Malaria
;
prevention & control
;
veterinary
;
Malaria Vaccines
;
immunology
;
Monkey Diseases
;
prevention & control
;
Plasmodium cynomolgi
;
Plasmodium falciparum
;
immunology
;
Recombinant Fusion Proteins
;
immunology
;
Vaccines, Synthetic
;
immunology
4.Identification of Immunodominant B-cell Epitope Regions of Reticulocyte Binding Proteins in Plasmodium vivax by Protein Microarray Based Immunoscreening.
Jin Hee HAN ; Jian LI ; Bo WANG ; Seong Kyun LEE ; Myat Htut NYUNT ; Sunghun NA ; Jeong Hyun PARK ; Eun Taek HAN
The Korean Journal of Parasitology 2015;53(4):403-411
Plasmodium falciparum can invade all stages of red blood cells, while Plasmodium vivax can invade only reticulocytes. Although many P. vivax proteins have been discovered, their functions are largely unknown. Among them, P. vivax reticulocyte binding proteins (PvRBP1 and PvRBP2) recognize and bind to reticulocytes. Both proteins possess a C-terminal hydrophobic transmembrane domain, which drives adhesion to reticulocytes. PvRBP1 and PvRBP2 are large (> 326 kDa), which hinders identification of the functional domains. In this study, the complete genome information of the P. vivax RBP family was thoroughly analyzed using a prediction server with bioinformatics data to predict B-cell epitope domains. Eleven pvrbp family genes that included 2 pseudogenes and 9 full or partial length genes were selected and used to express recombinant proteins in a wheat germ cell-free system. The expressed proteins were used to evaluate the humoral immune response with vivax malaria patients and healthy individual serum samples by protein microarray. The recombinant fragments of 9 PvRBP proteins were successfully expressed; the soluble proteins ranged in molecular weight from 16 to 34 kDa. Evaluation of the humoral immune response to each recombinant PvRBP protein indicated a high antigenicity, with 38-88% sensitivity and 100% specificity. Of them, N-terminal parts of PvRBP2c (PVX_090325-1) and PvRBP2 like partial A (PVX_090330-1) elicited high antigenicity. In addition, the PvRBP2-like homologue B (PVX_116930) fragment was newly identified as high antigenicity and may be exploited as a potential antigenic candidate among the PvRBP family. The functional activity of the PvRBP family on merozoite invasion remains unknown.
Epitopes, B-Lymphocyte/*chemistry/genetics/*immunology
;
Female
;
Humans
;
Immunodominant Epitopes/chemistry/genetics/*immunology
;
Malaria, Vivax/immunology/*parasitology
;
Middle Aged
;
Plasmodium vivax/chemistry/genetics/*immunology
;
Protein Structure, Tertiary
;
Protozoan Proteins/chemistry/genetics/*immunology
;
Reticulocytes/*parasitology
5.Development and Evaluation of an Immunochromatographic Kit for the Detection of Antibody to PLASMODIUM VIVAX Infection in South Korea.
Seung Kyu PARK ; Kil Whoan LEE ; Sung Hee HONG ; Dong Sup KIM ; John Hwa LEE ; Byung Hun JEON ; Won Sin KIM ; Ho Joon SHIN ; Seon Ho AN ; Hyun PARK
Yonsei Medical Journal 2003;44(4):747-750
Malaria is a major parasitic disease in tropical areas. Three to five hundred million people suffer from the disease and it kill a million people per year. Blood smear observation was developed for the diagnosis of malaria, but the examination needs skilled experts and exact diagnosis is time consuming. A kit based on immunochromatography can be a reliable and rapid method for clinical diagnosis, even in the hands of inexperienced personnel. However, all such currently developed kits can only diagnose P. falciparum malaria. In our previous report, the C-terminal region of P. vivax merozoite surface protein 1 (PvcMSP) was cloned and expressed in E. coli. In the present study, we developed an immunochromatographic kit using this PvcMSP for the diagnosis of specific antibody to P. vivax malaria in serum samples. The kit was used to examine sera from vivax malaria patients and non-malaria-infected person and the test showed 100% sensitivity (78/78) and 98.3% specificity (58/59). This result demonstrated that the immunochromatographic kit for P. vivax antibody detection is applicable for the rapid and precise diagnosis of P. vivax malaria.
Animals
;
Antibodies, Protozoan/*analysis
;
*Chromatography
;
Human
;
*Immunologic Techniques
;
Korea
;
Malaria, Vivax/*parasitology
;
Plasmodium vivax/*immunology
;
*Reagent Kits, Diagnostic/*standards
6.Age-Related CD4+CD25+Foxp3+ Regulatory T-Cell Responses During Plasmodium berghei ANKA Infection in Mice Susceptible or Resistant to Cerebral Malaria.
Ying SHAN ; Jun LIU ; Yan Yan PAN ; Yong Jun JIANG ; Hong SHANG ; Ya Ming CAO
The Korean Journal of Parasitology 2013;51(3):289-295
Different functions have been attributed to CD4+CD25+Foxp3+ regulatory T-cells (Tregs) during malaria infection. Herein, we describe the disparity in Treg response and pro- and anti-inflammatory cytokines during infection with Plasmodium berghei ANKA between young (3-week-old) and middle-aged (8-month-old) C57BL/6 mice. Young mice were susceptible to cerebral malaria (CM), while the middle-aged mice were resistant to CM and succumbed to hyperparasitemia and severe anemia. The levels of pro-inflammatory cytokines, such as TNF-alpha, in young CM-susceptible mice were markedly higher than in middle-aged CM-resistant mice. An increased absolute number of Tregs 3-5 days post-inoculation, co-occurring with elevated IL-10 levels, was observed in middle-aged CM-resistant mice but not in young CM-susceptible mice. Our findings suggest that Treg proliferation might be associated with the suppression of excessive pro-inflammatory Th1 response during early malaria infection, leading to resistance to CM in the middle-aged mice, possibly in an IL-10-dependent manner.
Aging/*immunology
;
Animals
;
Cytokines/genetics/metabolism
;
Female
;
Gene Expression Regulation
;
Malaria/*immunology/*parasitology
;
Mice
;
Plasmodium berghei/*classification
;
T-Lymphocytes, Regulatory/classification/*physiology
7.Evaluation of Rapid Diagnostics for Plasmodium falciparum and P. vivax in Mae Sot Malaria Endemic Area, Thailand.
Wanna CHAIJAROENKUL ; Thanee WONGCHAI ; Ronnatrai RUANGWEERAYUT ; Kesara NA-BANGCHANG
The Korean Journal of Parasitology 2011;49(1):33-38
Prompt and accurate diagnosis of malaria is the key to prevent disease morbidity and mortality. This study was carried out to evaluate diagnostic performance of 3 commercial rapid detection tests (RDTs), i.e., Malaria Antigen Pf/Pantrade mark, Malaria Ag-Pftrade mark, and Malaria Ag-Pvtrade mark tests, in comparison with the microscopic and PCR methods. A total of 460 blood samples microscopically positive for Plasmodium falciparum (211 samples), P. vivax (218), mixed with P. falciparum and P. vivax (30), or P. ovale (1), and 124 samples of healthy subjects or patients with other fever-related infections, were collected. The sensitivities of Malaria Ag-Pftrade mark and Malaria Antigen Pf/Pantrade mark compared with the microscopic method for P. falciparum or P. vivax detection were 97.6% and 99.0%, or 98.6% and 99.0%, respectively. The specificities of Malaria Ag-Pftrade mark, Malaria Ag-Pvtrade mark, and Malaria Antigen Pf/Pantrade mark were 93.3%, 98.8%, and 94.4%, respectively. The sensitivities of Malaria Ag-Pftrade mark, Malaria Antigen Pf/Pantrade mark, and microscopic method, when PCR was used as a reference method for P. falciparum or P. vivax detection were 91.8%, 100%, and 96.7%, or 91.9%, 92.6%, and 97.3%, respectively. The specificities of Malaria Ag-Pftrade mark, Malaria Ag-Pvtrade mark, Malaria Antigen Pf/Pantrade mark, and microscopic method were 66.2%, 92.7%, 73.9%, and 78.2%, respectively. Results indicated that the diagnostic performances of all the commercial RDTs are satisfactory for application to malaria diagnosis.
Antigens, Protozoan/blood
;
Cross-Sectional Studies
;
*Diagnostic Techniques and Procedures/instrumentation
;
Endemic Diseases/statistics & numerical data
;
Humans
;
Malaria/*diagnosis/epidemiology/parasitology
;
Malaria, Vivax
;
Plasmodium falciparum/genetics/immunology/*isolation & purification
;
Reagent Kits, Diagnostic
;
Thailand/epidemiology
8.ELISA detection of vivax malaria with recombinant multiple stage-specific antigens and its application to survey of residents in endemic areas.
Sera KIM ; Hye Jin AHN ; Tong Soo KIM ; Ho Woo NAM
The Korean Journal of Parasitology 2003;41(4):203-207
An ELISA was developed for the diagnosis of vivax malaria using multiple stage-specific recombinant antigens of Plasmodium vivax. The DNA from the whole blood of a malaria patient was used as template to amplify the coding regions for the antigenic domains of circumsporozoite protein (CSP-1), merozoite surface protein (MSP-1), apical merozoite antigen (AMA-1), serine repeat antigen (SERA), and exported antigen (EXP-1). Each amplified DNA fragment was inserted into pQE30 plasmid to induce the expression of His-tagged protein in Escherichia coli (M15 strain) by IPTG. His-tagged proteins were purified by Ni-NTA metal-affinity chromatography and used as antigens for ELISA with patient sera that were confirmed previously by blood smear examinations. When applied to patient sera, 122 (80.3%) out of 152 vivax malaria cases reacted to at least one antigen, while no reactions were observed with 128 uninfected serum samples. We applied this ELISA to the screening of 3, 262 civilian residents in endemic regions near the DMZ, which resulted in 236 positively detected (7.2%) cases. This method can be applied to serological diagnosis and mass screening in endemic regions, or can be used as a safety test for transfusion blood in endemic areas.
Animals
;
Antibodies, Protozoan/*blood
;
Antigens, Protozoan/genetics/*immunology
;
*Endemic Diseases
;
Enzyme-Linked Immunosorbent Assay/methods
;
Humans
;
Life Cycle Stages
;
Malaria, Vivax/*diagnosis/epidemiology/parasitology
;
Mass Screening
;
Plasmodium vivax/*growth & development/immunology
;
Recombinant Proteins/*immunology
;
Serologic Tests
9.In vivo antimalarial activity of synthetic hepcidin against Plasmodium berghei in mice.
Ya-Qun FANG ; Chuan-Bin SHEN ; Ning LUAN ; Hui-Min YAO ; Chen-Bo LONG ; Ren LAI ; Xiu-Wen YAN
Chinese Journal of Natural Medicines (English Ed.) 2017;15(3):161-167
The present study was designed to investigate the antimalarial activity of synthetic hepcidin and its effect on cytokine secretion in mice infected with Plasmodium berghei. The mice were infected with P. berghei intravenously and treated with hepcidin according to 4-day suppression test and Rane's test. The serum levels of interleukins (IL-1β, IL-2, IL-6, IL-10, IL-12p70, and IL-17A), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) in the experimental mice were determined using a cytometric bead array (CBA) kit. The survival rate of the infected mice was also registered. Additionally, the serum iron, alanine transaminase (ALT), aspartate transaminase (AST), and total bilirubin (BIL) were detected to evaluate liver functions. Hepcidin exerted direct anti-malarial function in vivo and increased survival rate in a dose-dependent manner. In addition, the secretion of T helper cell type 1 (Th1), Th2, and Th17 cytokines, TNF-α, and IFN-γ were inhibited by hepcidin. In conclusion, our results demonstrated that synthetic hepcidin exerts in vivo antimalarial activity and possesses anti-inflammatory function, which provides a basis for future design of new derivatives with ideal anti-malarial activity.
Animals
;
Antimalarials
;
chemical synthesis
;
pharmacology
;
Disease Models, Animal
;
Drug Evaluation, Preclinical
;
Hepcidins
;
chemical synthesis
;
pharmacology
;
Humans
;
Interleukin-10
;
immunology
;
Interleukin-17
;
immunology
;
Malaria
;
drug therapy
;
immunology
;
mortality
;
parasitology
;
Male
;
Mice
;
Plasmodium berghei
;
drug effects
;
genetics
;
metabolism
10.CD8+ T-cell Activation in Mice Injected with a Plasmid DNA Vaccine Encoding AMA-1 of the Reemerging Korean Plasmodium vivax.
Hyo Jin KIM ; Bong Kwang JUNG ; Jin Joo LEE ; Kyoung Ho PYO ; Tae Yun KIM ; Byung il CHOI ; Tae Woo KIM ; Hajime HISAEDA ; Kunisuke HIMENO ; Eun Hee SHIN ; Jong Yil CHAI
The Korean Journal of Parasitology 2011;49(1):85-90
Relatively little has been studied on the AMA-1 vaccine against Plasmodium vivax and on the plasmid DNA vaccine encoding P. vivax AMA-1 (PvAMA-1). In the present study, a plasmid DNA vaccine encoding AMA-1 of the reemerging Korean P. vivax has been constructed and a preliminary study was done on its cellular immunogenicity to recipient BALB/c mice. The PvAMA-1 gene was cloned and expressed in the plasmid vector UBpcAMA-1, and a protein band of approximately 56.8 kDa was obtained from the transfected COS7 cells. BALB/c mice were immunized intramuscularly or using a gene gun 4 times with the vaccine, and the proportions of splenic T-cell subsets were examined by fluorocytometry at week 2 after the last injection. The spleen cells from intramuscularly injected mice revealed no significant changes in the proportions of CD8+ T-cells and CD4+ T-cells. However, in mice immunized using a gene gun, significantly higher (P<0.05) proportions of CD8+ cells were observed compared to UB vector-injected control mice. The results indicated that cellular immunogenicity of the plasmid DNA vaccine encoding AMA-1 of the reemerging Korean P. vivax was weak when it was injected intramuscularly; however, a promising effect was observed using the gene gun injection technique.
Animals
;
Antigens, Protozoan/administration & dosage/genetics/*immunology
;
CD8-Positive T-Lymphocytes/*immunology
;
COS Cells
;
Cercopithecus aethiops
;
Humans
;
Lymphocyte Activation
;
Malaria, Vivax/*immunology/parasitology
;
Membrane Proteins/administration & dosage/genetics/*immunology
;
Mice
;
Mice, Inbred BALB C
;
Plasmodium vivax/genetics/*immunology
;
Protozoan Proteins/administration & dosage/genetics/*immunology
;
Protozoan Vaccines/administration & dosage/genetics/*immunology
;
Vaccines, DNA/administration & dosage/genetics/*immunology